Next Quarterly Earnings
Wednesday, November 4, 2026
CW 45
After-Hours
In 69 days
After-hours — after the market close (typically after 5:30 p.m. CET).
CRISPR Therapeutics
CRISPR Therapeutics is a leading biotechnology company based in Switzerland, specializing in the development of breakthrough gene-editing therapies. By leveraging CRISPR/Cas9 technology, the company addresses serious human diseases through the creation of innovative cell-based therapeutic candidates.
Frequently asked questions
When will CRISPR Therapeutics report its next quarterly earnings?
CRISPR Therapeutics is scheduled to report its next quarterly earnings on 11/04/2026. After-hours — after the market close (typically after 5:30 p.m. CET).
When did CRISPR Therapeutics last report quarterly earnings?
CRISPR Therapeutics last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at -0.94 USD.
How does CRISPR Therapeutics stock react to earnings?
Across its last 3 earnings reports, CRISPR Therapeutics stock moved by ±6.7% on average the following day. The largest reaction was +9.3% on 02/11/2025; 2 of 3 reactions were positive.
How often has CRISPR Therapeutics beaten expectations?
CRISPR Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
How do I add the CRISPR Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±6.7%
Avg. next-day move
+9.3%
Largest move (02/11/2025)
66.7%
Share of positive reactions
±14.8%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
3/5
Quarters above estimates
60%
Beat rate
-0.1%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
CRISPR Therapeutics
Country
More Financial Information